Carbon monoxide may enhance bile secretion by increasing glutathione excretion and Mrp2 expression in rats

被引:5
|
作者
Chen, Chiung-Yu [1 ]
Kao, Chi-Ya [2 ]
Lin, Po-Ju [2 ]
Shiesh, Shu-Chu [2 ]
机构
[1] Natl Cheng Kung Univ, Dept Internal Med, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 701, Taiwan
关键词
biliary secretion; carbon monoxide; glutathione; Mrp2; NITRIC-OXIDE; HEME OXYGENASE-1; LIVER; TRANSPORT; CHOLESTASIS; BILIRUBIN; MICE; FLOW;
D O I
10.1016/j.jcma.2013.02.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Nitric oxide (NO) donors have been reported to induce choleresis via an increased excretion of glutathione. The effects of another gas molecule, carbon monoxide (CO), on bile formation are, however, inconsistent among previous reports. We investigated the sequential changes of bile output and the biliary contents in rats with or without CO supplementation to elucidate the mechanism of CO on bile excretion. Methods: Dichloromethane (DCM) was gastrically fed to male Sprague-Dawley rats to yield CO by liver biotransformation. The rats were divided into DCM-treated (n = 7), DCM plus L-NAME-treated (n = 6), and corn oil-treated-(n = 8) groups. Bile samples were collected hourly to examine the flow rate and bile content. Serum levels of nitrite and nitrate 4 hours after DCM supplementation with or without NO synthase (NOS) inhibition were measured by capillary electrophoresis. The expression of hepatic inducible NOS was evaluated by Western blotting 6 hours after DCM administration. Results: Levels of carboxyhemoglobin rose to around 10% at 4 hours after DCM supplementation and were maintained until the end of the experiments. Bile flow increased after DCM supplementation and was associated with a concomitant increase of biliary glutathione and higher hepatic multidrug resistance-associated protein 2 (Mrp2) expression. Hepatic inducible NOS expression and serum nitrate/nitrite levels were also increased. Treatment with an NOS inhibitor (L-NAME) abolished the CO-induced glutathione excretion and choleresis, but not Mrp2 expression. Conclusion: The present study demonstrated that CO enhanced biliary output in conjunction with NO by increasing the biliary excretion of glutathione. The increment in biliary glutathione was associated with an increased expression of hepatic Mrp2 Copyright (C) 2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
引用
收藏
页码:258 / 264
页数:7
相关论文
共 50 条
  • [21] QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
    Ding, Congyang
    Li, Yajing
    Li, Xiao
    Meng, Lu
    Fu, Ran
    Wang, Xiaonan
    Li, Ying
    Ma, Yinling
    Dong, Zhanjun
    PHARMACEUTICAL BIOLOGY, 2022, 60 (01) : 185 - 194
  • [22] Talinolol is better absorbed and wider distributed in rats with defective MRP2 expression (TR-/GY)
    Bernsdorf, A
    May, K
    Möritz, KU
    Zschiesche, M
    Kunert-Keil, C
    Kroemer, HK
    Siegmund, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : R120 - R120
  • [23] Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal
    Ji, B
    Ito, K
    Suzuki, H
    Sugiyama, Y
    Horie, T
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (03) : 370 - 378
  • [24] Acetaminophen (AP) induces preferential expression of MRP3 vs MRP2 and increases urinary elimination of acetaminophenglucuronide (AG) in rats
    Ghanem, CI
    Ruiz, ML
    Villanueva, S
    Luquita, M
    Catania, VA
    Jones, B
    Bengochea, LA
    Vore, M
    Mottino, AD
    HEPATOLOGY, 2005, 42 (04) : 512A - 512A
  • [25] Specific microsomal enzyme inducers increase bile flow and biliary excretion of organic anions by induction of rat multidrug resistance protein 2 (Mrp2).
    Klaassen, CD
    Johnson, DR
    HEPATOLOGY, 1999, 30 (04) : 533A - 533A
  • [26] Hepatobiliary elimination of bile acid-modified oligodeoxynucleotides in Wistar and TR- rats:: evidence for mrp2 as carrier for oligodeoxynucleotides
    Lischka, K
    Starke, D
    Failing, K
    Herling, A
    Kramer, W
    Petzinger, E
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (04) : 565 - 577
  • [27] Expression of Multidrug Resistance Protein 2 (mrp2) in the Liver and Kidney Cells of Female Rats with Modeled Cholestasis of Pregnancy
    M. I. Aleksandrova
    N. S. Sirotina
    O. V. Smirnova
    Bulletin of Experimental Biology and Medicine, 2015, 158 : 748 - 752
  • [28] DELETION OF EBP50/NHERF-1 IN MICE RESULTS IN REDUCED HEPATIC MRP2 EXPRESSION AND BILE ACID INDEPENDENT BILE FLOW
    Li, Man
    Soroka, Carol J.
    Mennone, Albert
    Boyer, James L.
    HEPATOLOGY, 2009, 50 (04) : 308A - 308A
  • [29] Expression of Multidrug Resistance Protein 2 (mrp2) in the Liver and Kidney Cells of Female Rats with Modeled Cholestasis of Pregnancy
    Aleksandrova, M. I.
    Sirotina, N. S.
    Smirnova, O. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 158 (06) : 748 - 752
  • [30] Site and age-dependent expression of MDR1, BCRP and MRP2 in the gastrointestinal tract of rats
    MacLean, C
    Reichel, A
    Mertsch, K
    Fricker, G
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 17 - 17